BMAL1 and Alzheimer disease: The role of BMAL1 and circadian dysregulation in AD pathogenesis was confirmed in a recent study that demonstrated rhythmic DNA methylation associated with rhythmic BMAL1 transcription which was dysregulated during early AD progression [179].